These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31959539)

  • 1. Human B cells infected by Trypanosoma cruzi undergo F-actin disruption and cell death via caspase-7 activation and cleavage of phospholipase Cγ1.
    Dos Santos MA; Alves Martins F; Borges BC; de Gouveia Santos J; Nascimento Alves R; Dias MH; BrígidoTavares PC; E Silva Brígido RT; Teixeira TL; Costa Rodrigues C; Cota Teixeira S; da Costa MS; da Silva AA; Barbosa Silva MJ; de Melo Rodrigues Ávila V; Patriarca Mineo TW; de Souza MA; Bahia D; da Silva CV
    Immunobiology; 2020 May; 225(3):151904. PubMed ID: 31959539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Human CD11b
    Passos LSA; Magalhães LMD; Soares RP; Marques AF; Alves MLR; Giunchetti RC; Nunes MDCP; Gollob KJ; Dutra WO
    Front Immunol; 2018; 9():3015. PubMed ID: 30662439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Trypanosoma cruzi membrane protein shares an epitope with a lymphocyte activation antigen and induces crossreactive antibodies.
    Hernández-Munaín C; De Diego JL; Alcina A; Fresno M
    J Exp Med; 1992 Jun; 175(6):1473-82. PubMed ID: 1375261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Animal Model of Acute and Chronic Chagas Disease With the Reticulotropic Y Strain of
    Mateus J; Guerrero P; Lasso P; Cuervo C; González JM; Puerta CJ; Cuéllar A
    Front Immunol; 2019; 10():918. PubMed ID: 31105709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of the CCR5-CCL5 axis for mucosal Trypanosoma cruzi protection and B cell activation.
    Sullivan NL; Eickhoff CS; Zhang X; Giddings OK; Lane TE; Hoft DF
    J Immunol; 2011 Aug; 187(3):1358-68. PubMed ID: 21715689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenge of Trypanosoma cruzi chronically infected mice with trypomastigotes activates the immune system and reduces subpatent parasitemia levels.
    Marinho CR; Bastos KR; Sardinha LR; Grisotto MG; Lima MR; Alvarez JM
    J Parasitol; 2004 Jun; 90(3):516-23. PubMed ID: 15270095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase inhibition reduces lymphocyte apoptosis and improves host immune responses to Trypanosoma cruzi infection.
    Silva EM; Guillermo LV; Ribeiro-Gomes FL; De Meis J; Nunes MP; Senra JF; Soares MB; DosReis GA; Lopes MF
    Eur J Immunol; 2007 Mar; 37(3):738-46. PubMed ID: 17295391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma cruzi-induced molecular mimicry and Chagas' disease.
    Gironès N; Cuervo H; Fresno M
    Curr Top Microbiol Immunol; 2005; 296():89-123. PubMed ID: 16323421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Evasion Strategies of Trypanosoma cruzi.
    Flávia Nardy A; Freire-de-Lima CG; Morrot A
    J Immunol Res; 2015; 2015():178947. PubMed ID: 26240832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of antigen-specific B cells results in decreased Trypanosoma cruzi systemic but not mucosal immunity due to CD8 T cell exhaustion.
    Sullivan NL; Eickhoff CS; Sagartz J; Hoft DF
    J Immunol; 2015 Feb; 194(4):1806-18. PubMed ID: 25595788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein.
    Duthie MS; Wleklinski-Lee M; Smith S; Nakayama T; Taniguchi M; Kahn SJ
    Infect Immun; 2002 Jan; 70(1):36-48. PubMed ID: 11748161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Analysis of the Secretome and Interactome of
    Watanabe Costa R; Batista MF; Meneghelli I; Vidal RO; Nájera CA; Mendes AC; Andrade-Lima IA; da Silveira JF; Lopes LR; Ferreira LRP; Antoneli F; Bahia D
    Front Immunol; 2020; 11():1774. PubMed ID: 32973747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic experimental Chagas' disease: functional syngeneic T-B-cell cooperation in vitro in the absence of an exogenous stimulus.
    Freire-de-Lima C; Peçanha LM; Dos Reis GA
    Infect Immun; 1996 Jul; 64(7):2861-6. PubMed ID: 8698526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of Trypanosoma cruzi persistence in Chagas disease.
    Nagajyothi F; Machado FS; Burleigh BA; Jelicks LA; Scherer PE; Mukherjee S; Lisanti MP; Weiss LM; Garg NJ; Tanowitz HB
    Cell Microbiol; 2012 May; 14(5):634-43. PubMed ID: 22309180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Trypanosoma cruzi egress from infected fibroblasts is mediated by CD4+ and mu+ immune cells.
    Rowland EC; Chen Z
    J Parasitol; 2003 Aug; 89(4):733-7. PubMed ID: 14533683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice.
    Kotner J; Tarleton R
    Infect Immun; 2007 Feb; 75(2):861-9. PubMed ID: 17101658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular Vesicles Shed By
    Lovo-Martins MI; Malvezi AD; Zanluqui NG; Lucchetti BFC; Tatakihara VLH; Mörking PA; de Oliveira AG; Goldenberg S; Wowk PF; Pinge-Filho P
    Front Immunol; 2018; 9():896. PubMed ID: 29755471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response.
    Lopes MF; Nunes MP; Henriques-Pons A; Giese N; Morse HC; Davidson WF; Araújo-Jorge TC; DosReis GA
    Eur J Immunol; 1999 Jan; 29(1):81-9. PubMed ID: 9933089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.